clodronic acid has been researched along with Graft vs Host Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emerson, SG; Giannola, D; Joe, G; Louboutin, JP; Rivera, A; Shlomchik, WD; Zhang, Y; Zhu, J | 1 |
| Canninga-van Dijk, MR; de Weger, RA; Ebeling, SB; Hagenbeek, A; Hogenes, MC; Martens, AC; Rijkers, G; Simonetti, ER; Spits, H; Storm, G; van Bloois, L; van Rijn, RS; Weijer, K | 1 |
| Anderson, LD; Everse, LA; Mullen, CA; van Rooijen, N | 1 |
3 other study(ies) available for clodronic acid and Graft vs Host Disease
| Article | Year |
|---|---|
APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
Topics: Acute Disease; Animals; Antigen-Presenting Cells; Bone Marrow Transplantation; CD8-Positive T-Lymphocytes; Cell Movement; Clodronic Acid; Dendritic Cells; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Injections, Intravenous; Liposomes; Liver; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Organ Specificity; Spleen; Survival Rate | 2002 |
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
Topics: Animals; Antimetabolites; CD4-CD8 Ratio; Clodronic Acid; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Female; Gene Rearrangement, T-Lymphocyte; Graft vs Host Disease; Humans; Immunoglobulin G; Immunoglobulin M; Injections, Intravenous; Kidney; Leukocytes, Mononuclear; Liver; Lung; Macrophages; Male; Mice; Mice, Mutant Strains; Nuclear Proteins; Phenotype; Skin; Spleen; T-Lymphocytes; Titrimetry; Transplantation Chimera; Transplantation, Heterologous; Transplants | 2003 |
Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases PERI-BMT mortality.
Topics: Animals; Antigen-Presenting Cells; Blood Bactericidal Activity; Blood Component Removal; Bone Marrow Transplantation; Clodronic Acid; Female; Graft vs Host Disease; Histocompatibility; Injections, Intravenous; Liposomes; Mice; Mice, Inbred Strains; Reference Values; Severity of Illness Index; Toxins, Biological; Transplantation Conditioning | 2001 |